What do people at risk for Alzheimer disease think about surrogate consent for research?

Neurology

Volumn 65, Issue 9, 2005, Pages 1395-1401

  Kim, Scott Y H ^a,d   Kim, Hyungjin Myra ^b   McCallum, Colleen ^c   Tariot, Pierre N ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d Bioethics Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; VACCINE;

AGED; ALZHEIMER DISEASE; ATTITUDE; BRAIN BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; GENE TRANSFER; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; LUMBAR PUNCTURE; MALE; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION; POLICY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 27644529733     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000183144.61428.73     Document Type: Article

References (22)

1. Hoffmann D, Schwartz J. Proxy consent to participation of the decisionally impaired in medical research-Maryland's policy initiative. J Health Care Law Policy 1998;1:123-153.
2. National Bioethics Advisory Commission. Research involving persons with mental disorders that may affect decisionmaking capacity. Volume 1. Rockville, MD: NBAC, 1998.
3. Maryland Attorney General's Research Working Group. Final Report of the Attorney General's Research Working Group, 1998.
4. New York Department of Health Advisory Work Group on Human Subject Research Involving the Protected Classes. Recommendations on the oversight of human subject research involving the protected classes. Albany, NY: NY Department of Health, 1999.
5. Delano SJ. Research involving adults with decisional impairment. In: Amdur R, Bankert E, eds. Institutional review board: management and function. Sudbury, MA: Jones and Bartlett, 2002:389-393.
6. Keyserlingk EW. Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 1995;38:319-362.
7. Kim SYH, Appelbaum PS, Jeste DV, Olin JT. Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations. Am J Psychiatry 2004;161:797-806.
8. Sunderland T, Linker G, Mirza N, et al. Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003;289:2094-2103.
9. Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 2003;61:46-54.
10. Silverberg GD, Levinthal E, Sullivan EV, et al. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 2002;59:1139-1145.
11. Tuszynski MH, Sang H, Alksne J et al. Growth factor gene therapy for Alzheimer disease. Neurosurg Focus 2003; 13.
12. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817-830.
13. Streiner DL, Norman G. Health measurement scales, 3rd ed. New York: Oxford University Press, 2003.
14. Karlawish JHT, Casarett DJ, James BD, Xie SX, Kim SYH. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology 2005;64:1514-1519.
15. McQuillen MP, Tariot P. Who can say yes (or no) to a physician-and how does the physician know they can? Neurology 2005;64:1494-1495.
16. Kim SYH, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry 2001;158:712-717.
17. Wendler D, Martinez RA, Fairclough D, Sunderland T, Emanuel E. Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. Am J Psychiatry 2002;159:585-591.
18. Bravo G, Paquet M, Dubois MF. Opinions regarding who should consent to research on behalf of an older adult suffering from dementia. Int J Soc Res Pract 2003;2:49-65.
19. Kim SYH, Cox C, Caine ED. Impaired decision-making ability and willingness to participate in research in persons with Alzheimer's disease. Am J Psychiatry 2002;159:797-802.
20. Karlawish JHT, Knopman D, Clark CM, et al. Informed consent for Alzheimers disease clinical trials: a survey of clinical investigators. IRB 2002;24:1-5.
21. Schneider LS, Olin JT, Lyness SA, Chui HC. Eligibility of Alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc 1997;45:923-928.
22. Gutmann A, Thompson D. Deliberating about bioethics. Hastings Center Rep 1997;27:38-41.